McKinsey Issues a Rare Apology for Its Role in OxyContin Sales

The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay its distributors rebates for overdoses.The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay its distributors rebates for overdoses.Pain-Relieving Drugs, Opioids and Opiates, OxyContin (Drug), Drugs (Pharmaceuticals), Drug Abuse and Traffic, McKinsey & Co, Purdue Pharma, House of Representatives, Senate, Hawley, Josh D (1979- ), Murphy, Philip D (1957- ), Schatz, BrianRead More

Leave a Reply

Your email address will not be published.